Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Laura Lorenzetti
Stay informed with Laura Lorenzetti’s coverage and analysis for Coins2Day.
Page 43 of 73
Features
Apple’s Web TV and Nintendo’s Mario goes mobile — 5 things to know today
By
Editorial Team
Finance
Valeant comes out a winner after upping its Salix bid to $11.1 billion
By
Research Team
Features
JPMorgan hackers, Facebook’s standards and the debt ceiling — 5 things to know today
By
Financial Writer
Features
FBI probes Ackman and SXSW kicks off — 5 things to know today
By
Blockchain Reporter
Tech
Here are the 5 Apple ResearchKit apps you can start using now
By
News Correspondent
Features
Alibaba’s Snapchat deal and a Sikorsky spinoff — 5 things to know today
By
Industry Analyst
Leadership
These 11 companies offer 100% healthcare coverage
By
Senior Editor
Tech
Forget the Watch. Apple’s most meaningful debut is on the iPhone
By
News Correspondent
Tech
Exclusive: Healthcare startup Vitals brings in new CEO
By
Financial Writer
Features
Apple shareholders meet, Credit Suisse’s new CEO and Twitter in Hong Kong — 5 things to know today
By
Contributing Writer
Features
Apple’s Watch, GM’s deal, and Europe’s buying spree — 5 things to know today
By
Contributing Writer
Features
FDA approves the first biosimilar for the U.S. market
By
Industry Analyst
Finance
Workers rejoice: February hiring was huge with 295,000 jobs created
By
Investment Desk
Features
AbbVie’s $21 billion deal for Pharmacyclics — a sign of ‘desperation’?
By
News Correspondent
Features
China cuts growth and a big pharma deal — 5 things to know today
By
Contributing Writer